Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial [Phase 2]
Phase 2 clinical trial update evaluating durvalumab in combination with chemotherapy for locally advanced or metastatic solid tumors; the st…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring [Phase 1]
Phase 1 rollover study by Janssen Research & Development to continue study treatment and ongoing safety monitoring in patients with acute my…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors [Phase 1]
A Phase 1 clinical trial evaluating HCB301, an engineered Sirpα fusion with anti-PD-L1 and TGF-β activity, in patients with selected advance…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors [Phase 1]
A Phase 1 trial by the National Cancer Institute is evaluating the combination of Peposertib (M3814) and Tuvusertib (M1774) in patients with…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Veliparib, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin Lymphoma [Phase 1]
Phase 1 clinical trial evaluating veliparib in combination with cyclophosphamide and doxorubicin hydrochloride for patients with metastatic …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors [Phase 1]
Open-label Phase 1 clinical trial evaluating BBO-10203 in adults with advanced, metastatic solid tumors; currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01) [Phase 1, Phase 2]
A Phase 1/2 study evaluating patritumab deruxtecan in pediatric participants with relapsed or refractory solid tumors; recruitment is ongoin…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers [Phase 1]
Phase 1 clinical trial evaluating CBX-12 in adults with advanced solid tumors, including metastatic disease, is currently recruiting. The st…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Trial to Investigate the Safety of E303 in Participants With Advanced Refractory Solid Tumors [Phase 1]
This document reports an ongoing Phase 1 clinical trial to assess the safety of E303 in participants with advanced refractory solid tumors, …
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 study of TransCon TLR7/8 agonist with or without pembrolizumab in patients with advanced or metastatic solid tumors has been ter…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial to evaluate safety, pharmacokinetics, and preliminary efficacy of ONC 841 in patients with advanced solid tumors; cur…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma [Phase 1]
Phase 1 trial investigating riluzole in combination with sorafenib tosylate in patients with advanced solid tumors or melanoma; the study st…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors [NA]
An ongoing Mayo Clinic trial tests a collaborative intervention to improve cancer pain management in cancer survivors and is currently recru…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study of TRX-920 for Patients With Advanced Solid Tumors [Phase 1]
TaiRx, Inc. is recruiting for a Phase 1 study of TRX-920 in patients with advanced solid tumors.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study of ZE94-0605 in Patients With Advanced Solid Tumors, With Dose Expansion Cohorts. [Phase 1]
Phase 1 clinical trial update for ZE94-0605 in patients with advanced solid tumors, including dose expansion cohorts. The study is not yet r…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients (South Korea) [Phase 1]
Phase 1 trial of OTS-412, a recombinant oncolytic vaccinia virus, in treatment-refractory solid tumor patients in South Korea; currently rec…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of AI-081, a bispecific antibody targeting PD-1 and VEGF, in advanced solid tumors; the trial is evaluating safety, pharmaco…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacokinetics, and Preliminary Efficacy of FS-8002 [Phase 1]
Phase 1 clinical trial update for FS-8002 in advanced solid tumors. The study assesses safety, tolerability, pharmacokinetics, and prelimina…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Study to Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of [14C]-BMS-986504 (MRTX1719) in Participants With Advanced Solid Tumors With Homozygous Methylthioadenosine Phosphorylase Deletion [Phase 1]
Phase 1 study to evaluate mass balance, metabolism, elimination, and drug levels of radiolabeled BMS-986504 (MRTX1719) in participants with …
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating Dazostinag as a single agent and in combination with pembrolizumab in adults with advanced o…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors [Phase 1, Phase 2]
This clinical trials update notes ongoing Phase 1/2 studies of EIK1005, a Werner helicase inhibitor, as monotherapy and in combination with …
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating the safety, pharmacokinetics, and anti-tumor activity of VVD-133214 as monotherapy and in combination in participan…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials [Phase 4]
The FLOTILLA Phase 4 trial update describes continued access to encorafenib and binimetinib for participants who previously enrolled in rela…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer [EARLY_Phase 1]
A Phase 1 clinical trial update for the radiopharmaceutical 177Lu-IM-3050 evaluating safety and dosing in participants with solid tumors; th…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: JY016 Injection in Patients With Advanced Solid Tumors Expressing EGFR [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/Phase 2 study of JY016 for advanced solid tumors expressing EGFR, with the trial currently NO…